LifeSci Capital analyst Francois Brisebois initiated coverage of Mind Medicine (MNMD) with an Outperform rating and $32 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNMD:
- 3 Best Stocks to Buy Now, 10/13/2025, According to Top Analysts
- Mind Medicine’s MM120: Promising Phase 3 Trials and Strategic Growth Potential
- Mind Medicine initiated with a Buy at Needham
- Psychedelic: Exclusive talk with ibogaine clinic Beond
- MindMed Study Highlights Urgent Need for Suicide Risk Screening in GAD Patients